Back to search

Ireland· IE-PA-EU/1/21/1560/001-002

Celsunax 74 MBq/mL solution for injection

A iodine ioflupane (123i) product containing ioflupane (123i), registered in Ireland by Pinax Pharma GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC V09AB03

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedCelsunax 74 MBq/mL solution for injec…ATCV09AB03REGISTER NO.IE-PA-EU/1/21/1560/00…PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Iodine ioflupane (123i) is registered in 11 of 19 countries.

Countries holding a registration under ATC V09AB03 (iodine ioflupane (123i)), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 6 of them publish a price we can compare per daily dose

Iodine ioflupane (123i) · ATC V09AB03

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Ioflupane (123I)
Manufacturer
Pinax Pharma GmbH
Country
Ireland (IE)
ATC code
V09AB03
ATC class
Iodine ioflupane (123I)
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/21/1560/001-002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Iodine ioflupane (123i) in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iodine ioflupane (123i) products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Ioflupan (123i) Rotop
  • Belgium · Ioflupan (123i) Rotop, Ioflupane (123i) Rotop
  • Czechia · Joflupan (123i) Rotop
  • Germany · Ioflupan (123i) Rotop
  • Finland · Joflupaani (123i) Rotop
  • France · Ioflupane (123i) Rotop
  • United Kingdom (Northern Ireland) · Datscan, Ioflupane (123i) Rotop
  • Iceland · Datscan, Striascan
  • Italy · Ioflupane (123i) Rotop
  • Liechtenstein · Datscan
  • Luxembourg · Ioflupane (123i) Rotop
  • Netherlands · Joflupaan (123i) Rotop
  • Norway · Datscan, Ioflupane (123i) Rotop
  • Poland · Ioflupane (123i) Rotop
  • Portugal · Ioflupano (123i) Rotop
  • Sweden · Ioflupan (123i) Rotop

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bb027e52-8d7d-44f0-80d6-981f38901621
GET /v1/drugs/bb027e52-8d7d-44f0-80d6-981f38901621?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "V09AB03"
  ],
  "strength": null,
  "pa_number": "EU/1/21/1560/001-002",
  "substances": [
    "Ioflupane (123I)"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "17/06/2021",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about iodine ioflupane (123i).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.